BDPC (systematic name 4-(4-bromophenyl)-4-(dimethylamino)-1-(2-phenylethyl)cyclohexanol; also known as bromadol) is a potent narcotic analgesic with a distinctive arylcyclohexylamine chemical structure. It was developed by Daniel Lednicer at Upjohn in the 1970s. Initial studies estimated that it was around 10,000 times the strength of morphine in animal models. However, later studies using more modern techniques assigned a value of 504 times the potency of morphine for the more active trans-isomer. To date, it is unknown if this drug has been used by humans, however, it was seized along with three kilograms of acetylfentanyl in an April 25, 2013 police action in Montreal, Canada, and has reportedly continued to be available on the designer drug black market internationally. Analogues where the para-bromine is replaced by chlorine or CH3 retain similar activity, as does the meta-hydroxy derivative. (BDPC) (efficient name 4-(4-bromophenyl)– 4-(dimethylamino)– 1-(2-phenylethyl)cyclohexanol; otherwise called bromadol) is a strong opiate pain relieving with an unmistakable arylcyclohexylamine substance structure. Also, Initial studies assess that it is around 10,000 times the quality of morphine in creature models. However, later study show out an estimation of 504 times the strength of morphine for the more dynamic trans-isomer. Moreover, To date, it is obscure if this medication has been utilize by people. Notwithstanding, taking precautionary measures, no less than two officers got to be assign to take care of the drugs.